Tender detail
Open-house pharmaceutical discount agreements for lipegfilgrastim, ATC L03AA14
Summary
AOK Bayern plans to conclude identical, non-exclusive pharmaceutical discount agreements with interested companies for the active ingredient lipegfilgrastim (ATC L03AA14). The agreements may take effect from 1 January 2027 and end on 31 December 2028; they may be concluded during that period, up to 3 November 2028.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.